Skip to main content
. 2020 Jul 6;20:232. doi: 10.1186/s12877-020-01629-1

Table 1.

Person with dementia, descriptive data by severity of cognitive impairment

Mild Moderate Severe Sig. Test
Age, mean (SD) 80.2 (7.2) 82.4 (8.8) 80.0 (9.2) F = 2.50, p = 0.08
Gender: male, N (%) 62 (56.4%) 55 (55.6%) 34 (35.1%) χ2 = 11.62, p = 0.003
Residential status: care home (v own household), N (%) 6 (5.5%) 17 (17.0%) 40 (41.2%) χ2 = 41.59, p < 0.0001
Ethnicity: White British, N (%) 105 (96.3%) 88 (89.8%) 88 (90.7%) χ2 = 13.03, p = 0.37
Diagnosis: χ2 = 4.28, p = 0.83
AD, N (%) 63 (63.0%) 55 (57.9%) 58 (61.1%)
VaD, N (%) 13 (13.0%) 12 (12.6%) 14 (14.7%)
LBD, N (%) 2 (2.0%) 1 (1.1%) 3 (3.2%)
FTD, N (%) 4 (4.0%) 4 (4.2%) 1 (1.1%)
Other, N (%) 18 (18.0%) 23 (24.2%) 19 (20.0%)
sMMSE (↑ better cognition), mean (SD) 24.6 (0.2) 15.1 (2.9) 3.6 (3.2) F = 1360.36, p < 0.0001
QOL SELF-REPORT
DEMQOL (↑ better QoL), mean (SD) 90.5 (13.18) 92.8 (12.6) t = −1.23, p = 0.22
CASP total (↑ better QoL), mean (SD) 40.9 (9.5) 40.1 (8.0) t = 0.58 p = 0.61
EQ-5D Index (↑ better QoL), mean (SD) 0.8 (0.2) 0.8 (0.2) t = −0.08, p = 0.94
QOL PROXY-REPORT
DEMQOL-Proxy (↑ better QoL), mean (SD) 93.5 (13.7) 94.3 (14.4) 98.1 (13.0) F = 3.18, p = 0.04
EQ-5D-proxy Index (↑ better QoL), mean (SD) 0.7 (0.3) 0.5 (0.3) 0.4 (0.3) F = 26.76, p < 0.0001
COMORBIDITIES
NPI total (↑ more neuropsychiatric symptoms), mean (SD) 12.7 (11.0) 20.1 (15.5) 24.1 (16.3) F = 15.51, p < 0.0001

AD Alzheimer’s Disease, BADL Bristol Activities of Daily Living, CCI Charlson Comorbidity Index, FTD Frontotemporal Dementia, LBD Lewy Body Dementia, NPI Neuropsychiatric Inventory, QoL Quality of Life, sMMSE standardised Mini-Mental State Examination, OARS Older Adult Social Resource Scale, VaD Vascular Dementia

F = F statistic derived from one-way Analysis of Variance, t = t value derived from t-test, χ2 = Chi-square value derived from a Pearson’s Chi-square test